SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001000275-24-000026
Filing Date
2024-03-18
Accepted
2024-03-18 13:48:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2716
  Complete submission text file 0001000275-24-000026.txt   4122
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38079 | Film No.: 24758215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UROGEN PHARMA LTD. 9 HA TA ASIYA STREET RA ANANA L3 4365007
Business Address
Schoenberg Mark (Reporting) CIK: 0001763581 (see all company filings)

Type: 144